CF Foundation Supporting Development of Malabsorption Syndrome Therapy

The Cystic Fibrosis Foundation is supporting the development of Synspira's SNSP003, an orally-delivered non-porcine enzyme replacement therapy (ERT) designed to treat malabsorption syndromes.